Showing results (671-680 of 867) with videos related to

Sort By:
Pageof 87
Journal of Neuropathology and Experimental Neurology|May 26, 1998
Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristicsM Z Jones, J Alroy, P J Boyer, et al.
American Heart Journal|May 19, 2022
Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO studyFrederikus A Klok, Gregory Piazza, Andrew S P Sharp, et al.
JACC. Cardiovascular Interventions|January 7, 2022
1-Year Outcomes of Blinded Physiological Assessment of Residual Ischemia After Successful PCI: DEFINE PCI TrialManesh R Patel, Allen Jeremias, Akiko Maehara, et al.
Medrxiv : the Preprint Server for Health Sciences|July 30, 2026
Statin Use and Genetically Predicted HMG-CoA Reductase Inhibition in Relation to Clonal HematopoiesisPaul R Carter, Malgorzata Gozdecka, Sean Wen, et al.
Wellcome Open Research|May 13, 2017
PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohortColin P Sharp, William F Gregory, Louise Hattingh, et al.
Emerging Infectious Diseases|March 17, 2016
Evaluation of Viremia Frequencies of a Novel Human Pegivirus by Using Bioinformatic Screening and PCRDavid Bonsall, William F Gregory, Camilla L C Ip, et al.
Journal of Hypertension|October 17, 2017
Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IVRoland E Schmieder, Christian Ott, Stefan W Toennes, et al.
Leukemia|April 9, 2016
BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cellsZ Xu, P P Sharp, Y Yao, et al.
JACC. Cardiovascular Interventions|July 21, 2018
A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE TrialVictor F Tapson, Keith Sterling, Noah Jones, et al.
ACS Medicinal Chemistry Letters|March 18, 2026
N‑Alkyl and N‑Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy to Identify Orally Bioavailable Plasma Kallikrein InhibitorsRohan R Merchant, Natalia Chernyak, Jovan A Lopez, et al.
Pageof 87